CIBC assumed coverage of Nutrien (NTR) with an Outperformer rating and price target of $55, down from $60. With significant underutilized potash capacity, Nutrien is well positioned to benefit from favorable long-term demand for potash, the analyst tells investors in a research note. The firm sees limited potential for elevated potash pricing over the medium-term given upcoming industry capacity additions, but says Nutrien should drive free cash flow growth through further expansion of profitability in its Retail business. It also expects increased share repurchase activity supported by higher operating earnings and declining capex spending into 2025.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
- Raymond James upgrades Nutrien on ‘signs of life’ in potash
- Nutrien upgraded to Outperform from Market Perform at Raymond James
- BMO Says the S&P 500 Could Hit 6,700 in 2025 — Here Are 2 Stocks to Bet on It
- Nutrien Reports Q3 2024 Earnings Amid Strategic Initiatives
- Nutrien’s Q3 2024 Earnings Highlight Potash Success